Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

NCT06391918 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

37

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor strategic business decision

Conditions

Solid Tumor, Adult

Interventions

BIOLOGICAL: GEN2 + Valganciclovir

Sponsor

GenVivo, Inc.